Antiarrhythmic class drugs

2 results

  • Multaq

    (Dronedarone)
    Sanofi-Aventis U.S. LLC
    Usage: MULTAQ® is indicated for reducing the risk of hospitalization due to atrial fibrillation in patients with a history of paroxysmal or persistent atrial fibrillation who are in sinus rhythm.

  • Sotylize

    (SOTALOL HYDROCHLORIDE)
    Azurity Pharmaceuticals, Inc.
    Usage: SOTYLIZE is indicated for treating life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia, and for delaying the recurrence of highly symptomatic atrial fibrillation/atrial flutter in patients currently in sinus rhythm. It is not proven to enhance survival in these conditions.